Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bartsch

Showing results (91-100 of 512) with videos related to

Pageof 52
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1986
Metabolic host factors as modifiers of reactive intermediates possibly involved in human cancerE Hietanen, H Bartsch, H Vainio
Biochimica Et Biophysica Acta|June 22, 1971
On the metabolic activation of N-hydroxy-N-2-acetylamino-fluorene. II. Simultaneous formation of 2-nitrosofluorene and N-acetoxy-N-2-acetylaminofluorene from N-hydroxy-N-2-acetylaminofluorene via a free radical intermediateH Bartsch, M Traut, E Hecker
Carcinogenesis|January 1, 1983
Evaluation of DNA damage by the alkaline elution technique in liver, kidneys and lungs of rats and hamsters treated with N-nitrosodialkylaminesA Barbin, J C Béréziat, H Bartsch
Voprosy Onkologii|January 1, 1981
[Metabolic activation and the mutagenic properties of carcinogenic N-nitramines in a liquid incubation test]V V Khudoleĭ, H Bartsch, C Malaveille
Gut|January 22, 2000
Generation of reactive oxygen species by the faecal matrixR W Owen, B Spiegelhalder, H Bartsch
Carcinogenesis|January 1, 1982
Monitoring N-nitrosamino acids excreted in the urine and feces of rats as an index for endogenous nitrosationH Ohshima, J C Bereziat, H Bartsch
Cancer Research|June 1, 1985
Lack of miscoding properties of 7-(2-oxoethyl)guanine, the major vinyl chloride-DNA adductA Barbin, R J Laib, H Bartsch
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 11, 1998
Phytate, reactive oxygen species and colorectal cancerR W Owen, B Spiegelhalder, H Bartsch
Voprosy Onkologii|January 1, 1981
[In vivo and in vitro studies of mutagenic properties of carcinogenic N-nitramines]V V Khudoleĭ, C Malaveille, H Bartsch
In Vivo (Athens, Greece)|July 1, 1995
Rationales to consider the use of melatonin as a chrono-oncotherapeutic drugC Bartsch, H Bartsch, T H Lippert
Pageof 52

Showing results (91-100 of 512) with videos related to

Sort By:
Pageof 52
Advances in Experimental Medicine and Biology|January 1, 1986
Metabolic host factors as modifiers of reactive intermediates possibly involved in human cancerE Hietanen, H Bartsch, H Vainio
Biochimica Et Biophysica Acta|June 22, 1971
On the metabolic activation of N-hydroxy-N-2-acetylamino-fluorene. II. Simultaneous formation of 2-nitrosofluorene and N-acetoxy-N-2-acetylaminofluorene from N-hydroxy-N-2-acetylaminofluorene via a free radical intermediateH Bartsch, M Traut, E Hecker
Carcinogenesis|January 1, 1983
Evaluation of DNA damage by the alkaline elution technique in liver, kidneys and lungs of rats and hamsters treated with N-nitrosodialkylaminesA Barbin, J C Béréziat, H Bartsch
Voprosy Onkologii|January 1, 1981
[Metabolic activation and the mutagenic properties of carcinogenic N-nitramines in a liquid incubation test]V V Khudoleĭ, H Bartsch, C Malaveille
Gut|January 22, 2000
Generation of reactive oxygen species by the faecal matrixR W Owen, B Spiegelhalder, H Bartsch
Carcinogenesis|January 1, 1982
Monitoring N-nitrosamino acids excreted in the urine and feces of rats as an index for endogenous nitrosationH Ohshima, J C Bereziat, H Bartsch
Cancer Research|June 1, 1985
Lack of miscoding properties of 7-(2-oxoethyl)guanine, the major vinyl chloride-DNA adductA Barbin, R J Laib, H Bartsch
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 11, 1998
Phytate, reactive oxygen species and colorectal cancerR W Owen, B Spiegelhalder, H Bartsch
Voprosy Onkologii|January 1, 1981
[In vivo and in vitro studies of mutagenic properties of carcinogenic N-nitramines]V V Khudoleĭ, C Malaveille, H Bartsch
In Vivo (Athens, Greece)|July 1, 1995
Rationales to consider the use of melatonin as a chrono-oncotherapeutic drugC Bartsch, H Bartsch, T H Lippert
Pageof 52